Telix Pharmaceuticals (TLX) Goodwill (2024 - 2025)

Telix Pharmaceuticals (TLX) has disclosed Goodwill for 2 consecutive years, with $199.0 million as the latest value for Q4 2025.

  • Quarterly Goodwill rose 198.84% to $199.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $199.0 million through Dec 2025, up 198.84% year-over-year, with the annual reading at $199.0 million for FY2025, 198.84% up from the prior year.
  • Goodwill for Q4 2025 was $199.0 million at Telix Pharmaceuticals, up from $66.6 million in the prior quarter.
  • The five-year high for Goodwill was $199.0 million in Q4 2025, with the low at $66.6 million in Q4 2024.